Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin in critically ill patients for small intestinal transit and glucose absorption
ACTRN12610000615088Phase 2Completed
- Sponsor
- Adam Deane
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of erythromycin in critical illness (2 arms), sponsored by Adam Deane. Primary endpoints: Glucose absorption, Lipid absorption and 1 more. Started Jun 2010; status: completed.
02
Drugs
erythromycin
03
Conditions
critical illness
Beyond the preview
Go deeper on ACTRN12610000615088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000615088.